Gimv
Portfolio in Switzerland · Germany: 3 funded startups tracked by Uback, 0 of them in a ranking.
Portfolio on Uback3startups, 2 countries
In a ranking0ranked by AI-estimated valuation
On the Radar3eligible, not ranked
Latest deal trackedJan 2026Exciva
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| Exciva | Radar | Biotech › neuropsychiatry | Series B · EUR 51M (USD 59M) · Jan 2026 | Not estimated |
| ImmunOs Therapeutics | Radar | Biotech › immunotherapy | Series C · USD 11M · Sep 2024 | Not estimated |
| sofatutor | Radar | Edtech & future of work › K-12 › Tutoring | Private equity investment · Mar 2021 | Not estimated |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
12021
02022
02023
12024
02025
12026
Co-investors
Fountain Healthcare Partners · Pfizer Ventures · Mission BioCapital · BioMed Partners · Double Point Ventures · EMERAM Capital Partners
Investors that joined the same rounds, as reported by public sources.
Last updated: Oct 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.